Home > PS Ratio > NGL FINECHEM

NGL FINECHEM
PS (Price/Sales) Ratio

The Current P/S Ratio of NGL FINECHEM is 2.70.

Share Price ₹1,619.2Feb 01,2025
Market Cap ₹1,003.9 Cr
Sales-TTM₹372.0 CrTTM-Consolidated Results
Price/Sales2.70xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results
NGL FINECHEM is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PS (Price/Sales) ratio of NGL FINECHEM

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of NGL FINECHEM is calculated as :

Current Market Cap [ ₹1,003.9 Cr] as on Feb 01,2025

(/) Sales [ ₹372.0 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 2.70x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for NGL FINECHEM , the investors are currently willing to pay '2.70 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of NGL FINECHEM !

The chart below summarizes the trend in P/S Ratio of NGL FINECHEM over the last five years.

Historical PS (Price/Sales) ratio chart of NGL FINECHEM


PS Ratio Performance Analysis for NGL FINECHEM

- NGL FINECHEM 's latest p/e ratio is 2.70x.

- NGL FINECHEM 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.00x.

- NGL FINECHEM 's operated at median p/e ratio of 3.67x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, NGL FINECHEM 's p/e ratio peaked in Mar2024 at 3.81x.

- NGL FINECHEM 's p/e ratio hit its five-year low in Mar2020 of 1.03x.


How does NGL FINECHEM 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
NGL FINECHEM 372.02.701,003.9
SUN PHARMACEUTICAL INDUSTRIES LTD51,602.58.10418,132.0
CIPLA LTD26,981.24.30116,123.0
DR REDDYS LABORATORIES LTD31,229.33.22100,573.0
ZYDUS LIFESCIENCES LTD21,483.54.5697,966.9
DIVIS LABORATORIES LTD8,614.017.33149,254.0
MANKIND PHARMA LTD11,641.08.79102,348.0
TORRENT PHARMACEUTICALS LTD11,302.09.60108,477.0
LUPIN LTD21,431.34.3893,813.7
AUROBINDO PHARMA LTD30,295.02.1966,385.6
ABBOTT INDIA LTD6,066.19.0855,059.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs NGL FINECHEM 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.19x
Max industry PS 17.33x
Median industry PS 4.56x
Average industry PS 6.75x



You may also like the below Video Courses